Drug intelligence / Profile preview

Celadrin

Development stage
Unknown
Lead developer
EverWell
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Celadrin is a proprietary blend of cetylated, esterified fatty acids (CFAs) used as a dietary supplement and topical analgesic for the relief of joint and muscle pain associated with osteoarthritis, strains, and sprains. Developed and marketed by Factors Group of Nutritional Products, it is available in oral softgel and topical cream formulations. The mixture typically includes cetyl myristoleate, cetyl myristate, cetyl palmitoleate, cetyl laureate, cetyl palmitate, and cetyl oleate. Its mechanism of action involves the stabilization of cell membranes, reduction of inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor (TNF), and inhibition of the cyclooxygenase-2 (COX-2) enzyme. By enhancing membrane fluidity and integrity, Celadrin aims to reduce inflammation and support joint health and mobility.

Brand names
Celadrin
Other names
cetylated fatty acidsesterified fatty acidsCFA
02

Targets

IL-6 (Interleukin 6)

Beyond the preview

Go deeper on Celadrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celadrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call